about
Antipsychotics for fibromyalgiaSelective serotonin reuptake inhibitors for fibromyalgia syndromeCannabinoids for fibromyalgiaAnticonvulsants for fibromyalgiaMonoamine oxidase inhibitors (MAOIs) for fibromyalgia syndromeSerotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndromeAnti-depressants and centrally active agents for fibromyalgia syndromeNSAIDs, analgesics and opioids agents for fibromyalgia syndromeCannabinoids for fibromyalgiaChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyNeuroimaging the brain-gut axis in patients with irritable bowel syndromePredictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative.Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial.Increased brain white matter axial diffusivity associated with fatigue, pain and hyperalgesia in Gulf War illness.Understanding the Association of Fatigue With Other Symptoms of Fibromyalgia: Development of a Cluster ModelPredictors of change in pain and physical functioning among post-menopausal women with recurrent pain conditions in the women's health initiative observational cohortThe Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview SurveyThree-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview SurveySelf-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.Comparing Genomic Profiles of Women With and Without Fibromyalgia.Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: a preliminary report.Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials.Review of pharmacological therapies in fibromyalgia syndrome.Meta-analysis of the effects of lifestyle modifications on coronary and carotid atherosclerotic burden.Sjögren Syndrome and Other Causes of Sicca in Older Adults.2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria.Quantifying the influence of child abuse history on the cardinal symptoms of fibromyalgia.Comparison of Physician-Based and Patient-Based Criteria for the Diagnosis of Fibromyalgia.Pericardial tamponade as the initial presentation in a patient with polymyositis.No Association of Fibromyalgia and Seronegative Rheumatoid Arthritis-The Need for Uniform Application of Fibromyalgia Criteria in Research Studies: Comment on the Article by Doss et al.Fibromyalgia Is Overdiagnosed in the General Population: Comment on the Article by Hootman et al.Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice.Culture, science and the changing nature of fibromyalgia.Mortality in fibromyalgia: a study of 8,186 patients over thirty-five years.Femoral profunda artery aneurysm as an unusual first presentation of Behcet disease.WITHDRAWN: Anticonvulsants for fibromyalgia.The effects of multidisciplinary therapy on positron emission tomography of the brain in fibromyalgia: a pilot study.The longitudinal outcome of fibromyalgia: a study of 1555 patients.Automated neuropsychiatric measurements of information processing in fibromyalgia.
P50
Q24186761-AAF63074-A268-4B6D-A033-856DF75AD73BQ24187263-4AB678E2-ED41-4201-BD63-94594EABA056Q24188267-390C2F1F-943F-4E7A-BACE-E0A241D9451FQ24197464-2AA9F07A-53D4-43F7-85BC-1395CFBB3C30Q24200385-8421D8E7-DB03-4BE0-9D91-6BA963399837Q24201799-1969A5B2-D549-4A44-AAA4-915C144166A6Q24244688-32CB1725-77E4-48B7-8D3C-8EDCB2D2C001Q24245928-68CCEDBD-64C3-4EB2-946E-A89B01C266D5Q26471052-3FCD0FD9-0B4B-4BDF-8BB5-EEC4A3919434Q27011451-1A1A92AD-DC85-4551-94C7-2BD994B1314CQ31093698-E9B44727-6310-4B9F-BAD5-E59A4702C025Q33621133-A63D8AC9-E83B-4712-BCC0-87B970D82DCCQ33939390-F1EDE755-1956-4501-8775-5137CFFCCBDFQ34634171-5E0DFB26-DF4F-4D7A-A4AA-BB353CD0C816Q35643767-D26A509D-02A0-4676-8559-7249B0EED2F5Q35645826-943F71A2-5BC1-4FC8-A114-AE8BD5861582Q35778493-9177D0CB-7373-4ECB-A309-878F4A4EE2E4Q36047043-980BF932-D3B8-4394-989D-F1E6F4DB3634Q36570793-90050D48-A53E-4DA5-8B6C-38F633512FF6Q36584919-D605F655-AFE3-4C6A-837F-65D5257A63EDQ36601482-64FB0F0D-A63A-4524-AA87-10A5377152B8Q37038024-3CABD916-9AC6-4024-A1A8-27889F71D657Q37140905-370F31BF-3A9D-416D-A756-585E1CDF6205Q37691161-E8EB11A1-5ED9-4DC2-9BF5-4EA9AB374691Q38281440-03CEC60F-C90F-4562-BE38-ED1ECC191C30Q39019614-4B32A7FD-6C40-4DC8-8A8F-56E004C8323AQ39132625-89EF3CFB-3DA6-483B-840F-7503F7252026Q40131318-06BB1F41-8769-43BE-BC08-AB843A7984BAQ40491984-536BC223-1E22-47CB-9879-A5B9DF524DF7Q42920953-C787ECF2-CAD4-481F-A9AF-3C6DC69F8E65Q44194868-9CAF32AE-41CC-462E-8FFC-693A5C95E3E2Q44433790-3197056A-E359-40BE-BFFA-5C9F02B488DEQ44940438-CC0033F9-AA06-46DD-B5F1-00DC7FC876D9Q45817582-D0738F0F-FE25-450A-AD70-EBD69658C80CQ45862773-C78459E0-AFFD-4258-84E9-2871F5D496D4Q46738164-DC21D99B-7052-4AA8-B839-05AA1BFFFB7FQ47676478-4C5F16B4-253B-4E00-9A70-E3B9A9D34DEAQ48102830-27ADEB3E-7E1C-443F-BB08-A4465A23DCE5Q48292791-C54AFD2F-1617-43F0-9BC4-05625D9483F3Q51896927-8D70E3D1-2FA6-42AB-AEC5-CD4AD3ABC920
P50
name
Brian Walitt
@ast
Brian Walitt
@en
Brian Walitt
@es
Brian Walitt
@nl
type
label
Brian Walitt
@ast
Brian Walitt
@en
Brian Walitt
@es
Brian Walitt
@nl
prefLabel
Brian Walitt
@ast
Brian Walitt
@en
Brian Walitt
@es
Brian Walitt
@nl